Fortive Corp (FTV)

NYSE
Currency in USD
79.09
-0.75(-0.94%)
Closed
Pre Market
79.12+0.03(+0.04%)
FTV Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
77.7680.34
52 wk Range
66.1587.10
Key Statistics
Edit
Prev. Close
79.09
Open
80
Day's Range
77.76-80.34
52 wk Range
66.15-87.1
Volume
4.26M
Average Volume (3m)
2.5M
1-Year Change
-4.37%
Book Value / Share
29.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FTV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
89.48
Upside
+13.14%
Members' Sentiments
Bearish
Bullish
ProTips
6 analysts have revised their earnings downwards for the upcoming period
Show more

Fortive Corp Company Profile

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Fortive Corp SWOT Analysis


Strategic Spin-off
Fortive's planned spin-off of its Precision Technologies segment aims to create focused, independent companies, potentially unlocking significant shareholder value
Resilient Transformation
Explore Fortive's transition towards a less cyclical business model with higher margins and recurring sales, enhancing long-term stability and profitability
Market Headwinds
Learn how Fortive navigates challenges in China and government spending delays, impacting its Intelligent Operating Solutions segment and overall growth
Analyst Perspectives
Average price target of $84.38, with estimates ranging from $77 to $96, reflecting varied views on Fortive's growth potential and strategic initiatives
Read full SWOT analysis

Fortive Corp Earnings Call Summary for Q2/2024

  • Q2 revenue up 2%, earnings at high end of guidance; full-year growth forecast 3-4%, adjusted EPS $3.80-$3.86
  • Intelligent Operating Solutions and Advanced Healthcare Solutions excel; Precision Technologies declines on lower volumes
  • Core growth improvement expected in H2; $8B+ free cash flow projected with ongoing buybacks and dividend increases
  • China recovery slower than anticipated; tech core revenue expected to decline low-double digits in Q3 and Q4
  • Focus on recurring revenue and innovation; $1B+ funnel of new market opportunities despite geopolitical uncertainties
Last Updated: 07/25/2024, 04:40 PM
Read Full Transcript

Compare FTV to Peers and Sector

Metrics to compare
FTV
Peers
Sector
Relationship
P/E Ratio
32.4x28.9x11.9x
PEG Ratio
−11.250.450.03
Price/Book
2.6x6.2x1.4x
Price / LTM Sales
4.3x4.2x1.2x
Upside (Analyst Target)
12.5%29.8%23.4%
Fair Value Upside
Unlock−9.7%6.3%Unlock

Analyst Ratings

13 Buy
8 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 89.48
(+13.14% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.39
Dividend Yield
0.40%
Industry Median 1.15%
Annualized payout
0.3200
Paid quarterly
5-Years Growth
+2.71%
Growth Streak

Earnings

Latest Release
Feb 07, 2025
EPS / Forecast
1.17 / 1.12
Revenue / Forecast
1.62B / 1.63B
EPS Revisions
Last 90 days

People Also Watch

511.56
TDY
+0.31%
98.81
VLTO
+0.38%
679.24
AXON
+0.27%
118.47
ANET
+2.78%
206.76
DHR
-1.55%

FAQ

What Is the Fortive (FTV) Stock Price Today?

The Fortive stock price today is 79.09

What Stock Exchange Does Fortive Trade On?

Fortive is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Fortive?

The stock symbol for Fortive is "FTV."

Does Fortive Pay Dividends? What’s The Current Dividend Yield?

The Fortive dividend yield is 0.40%.

What Is the Fortive Market Cap?

As of today, Fortive market cap is 26.99B.

What is Fortive Earnings Per Share?

The Fortive EPS is 2.39.

What Is the Next Fortive Earnings Date?

Fortive will release its next earnings report on Apr 23, 2025.

From a Technical Analysis Perspective, Is FTV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.